Search Results - Lim KS
- Showing 1 - 12 results of 12
-
1
Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination... by Choi YJ, Han HK, Shin D, Lim KS, Yu KS
Published 2015Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers by Lee J, Lee H, Jang K, Lim KS, Shin D, Yu KS
Published 2014Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Effect of renal function on the pharmacokinetics of fimasartan: a single-dose, open-label, Phase I study by Kim S, Lee J, Shin D, Lim KS, Kim YS, Jang IJ, Yu KS
Published 2014Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in hea... by Park SI, Lee H, Oh J, Lim KS, Jang IJ, Kim JA, Jung JH, Yu KS
Published 2015Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
5
-
6
-
7
Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state by Jang K, Yoon S, Kim SE, Cho JY, Yoon SH, Lim KS, Yu KS, Jang IJ, Lee H
Published 2014Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
8
Pharmacokinetic-pharmacodynamic analysis to evaluate the effect of moxifloxacin on QT interval prolongation in healthy Korean male subjects by Hong T, Han S, Lee J, Jeon S, Park GJ, Park WS, Lim KS, Chung JY, Yu KS, Yim DS
Published 2015Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
9
Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjects by Cha YJ, Lim KS, Park MK, Schneider S, Bray B, Kang MC, Chung JY, Yoon SH, Cho JY, Yu KS
Published 2014Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
10
A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profiles by Chung H, Lee H, Han H, An H, Lim KS, Lee YJ, Cho JY, Yoon SH, Jang IJ, Yu KS
Published 2015Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
11
A first-in-human study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of KM-819 (FAS-associated factor 1 inhibitor), a drug for Parkinson’s d... by Shin W, Lim KS, Kim MK, Kim HS, Hong J, Jhee S, Kim J, Yoo S, Chung YT, Lee JM, Cho DY
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
12
Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers by Gu N, Park MK, Kim TE, Bahng MY, Lim KS, Cho SH, Yoon SH, Cho JY, Jang IJ, Yu KS
Published 2014Call Number: Loading…Connect to this object online.
Located: Loading…
Book